Dawn Sievert

10.2k total citations · 5 hit papers
27 papers, 7.9k citations indexed

About

Dawn Sievert is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Clinical Biochemistry. According to data from OpenAlex, Dawn Sievert has authored 27 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 12 papers in Applied Microbiology and Biotechnology and 11 papers in Clinical Biochemistry. Recurrent topics in Dawn Sievert's work include Antibiotic Use and Resistance (12 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). Dawn Sievert is often cited by papers focused on Antibiotic Use and Resistance (12 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). Dawn Sievert collaborates with scholars based in United States, Switzerland and Germany. Dawn Sievert's co-authors include Jonathan R. Edwards, Jean B. Patel, Scott K. Fridkin, Daniel A. Pollock, Alicia Hidrón, Teresa Horan, Brandi Limbago, Margaret A. Dudeck, Lindsey M. Weiner and Jeffrey Hageman and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Clinical Infectious Diseases.

In The Last Decade

Dawn Sievert

25 papers receiving 7.6k citations

Hit Papers

Antimicrobial-Resistant Pathogens Associated With Healthc... 2003 2026 2010 2018 2008 2012 2016 2003 2013 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
    2008 3.1k citations Alicia Hidrón, Jonathan R. Edwards et al. Infection Control and Hospital Epidemiology profile →
  2. Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
    2012 1.2k citations Dawn Sievert, Philip Ricks et al. Infection Control and Hospital Epidemiology profile →
  3. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014
    2016 964 citations Lindsey M. Weiner, Margaret A. Dudeck et al. Infection Control and Hospital Epidemiology profile →
  4. Infection with Vancomycin-ResistantStaphylococcus aureusContaining thevanAResistance Gene
    2003 852 citations Dawn Sievert, Jeffrey Hageman et al. New England Journal of Medicine profile →
  5. National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module
    2013 461 citations Margaret A. Dudeck, Lindsey M. Weiner et al. American Journal of Infection Control profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn Sievert United States 14 3.5k 2.4k 2.2k 1.9k 1.6k 27 7.9k
Hilmar Wisplinghoff Germany 40 4.4k 1.3× 3.6k 1.5× 2.3k 1.0× 1.6k 0.9× 1.7k 1.1× 97 8.7k
Mary K. Hayden United States 47 4.4k 1.3× 1.8k 0.8× 1.9k 0.8× 2.1k 1.1× 969 0.6× 180 7.6k
Mario Venditti Italy 54 3.8k 1.1× 4.3k 1.8× 2.2k 1.0× 1.4k 0.7× 1.1k 0.7× 281 9.7k
Emilia Cercenado Spain 43 2.5k 0.7× 2.6k 1.1× 1.6k 0.7× 1.7k 0.9× 995 0.6× 245 6.5k
Jan Kluytmans Netherlands 42 3.1k 0.9× 2.1k 0.9× 2.4k 1.1× 1.5k 0.8× 1.8k 1.1× 199 8.5k
Kyong Ran Peck South Korea 51 3.6k 1.0× 3.7k 1.6× 3.2k 1.4× 1.5k 0.8× 1.5k 0.9× 443 10.0k
Alexander J. Kallen United States 36 1.9k 0.5× 1.8k 0.8× 2.5k 1.1× 1.2k 0.6× 854 0.5× 101 6.3k
Àlex Soriano Spain 50 3.4k 1.0× 2.9k 1.2× 1.4k 0.6× 1.8k 0.9× 853 0.5× 431 10.0k
Susan M. Ray United States 35 4.4k 1.3× 2.3k 1.0× 788 0.4× 1.7k 0.9× 1.4k 0.9× 124 8.3k
Javier Garau Spain 53 2.3k 0.7× 4.8k 2.0× 2.2k 1.0× 1.1k 0.6× 1.3k 0.8× 208 10.9k

Countries citing papers authored by Dawn Sievert

Since Specialization
Citations

This map shows the geographic impact of Dawn Sievert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Sievert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Sievert more than expected).

Fields of papers citing papers by Dawn Sievert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn Sievert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Sievert. The network helps show where Dawn Sievert may publish in the future.

Co-authorship network of co-authors of Dawn Sievert

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Sievert. A scholar is included among the top collaborators of Dawn Sievert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Sievert. Dawn Sievert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolford, Hannah, Natalie McCarthy, James Baggs, et al.. (2025). Antimicrobial-Resistant Infections in Hospitalized Patients. JAMA Network Open. 8(3). e2462059–e2462059. 6 indexed citations
2.
Craig, Michael, Daniel B. Jernigan, Kayla Laserson, et al.. (2024). Antimicrobial resistance at a crossroads: the cost of inaction. The Lancet. 404(10458). 1083–1085. 2 indexed citations
3.
Lessa, Fernanda C. & Dawn Sievert. (2023). Antibiotic Resistance: A Global Problem and the Need to Do More. Clinical Infectious Diseases. 77(Supplement_1). S1–S3. 16 indexed citations
4.
Santos, Carlos A.Q., et al.. (2023). Comparative antimicrobial use in coronavirus disease 2019 (COVID-19) and non–COVID-19 inpatients from 2019 to 2020: A multicenter ecological study. Infection Control and Hospital Epidemiology. 45(3). 335–342.
5.
Tomczyk, Sara, Allison C. Brown, Marlieke E.A. de Kraker, et al.. (2021). Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. Journal of Antimicrobial Chemotherapy. 76(11). 3045–3058. 113 indexed citations
6.
Sievert, Dawn, Amy Kirby, & L. Clifford McDonald. (2021). The CDC response to antibiotic and antifungal resistance in the environment. Med. 2(4). 365–369. 7 indexed citations
7.
Forsberg, Kaitlin, Meghan Lyman, Sudha Chaturvedi, et al.. (2020). 155. Public Health Action-based System for Tracking and Responding to U.S. candida Drug Resistance: AR Lab Network, 2016–2019. Open Forum Infectious Diseases. 7(Supplement_1). S206–S207. 4 indexed citations
8.
Maurer, Florian P., Dawn Sievert, Doris Hillemann, et al.. (2018). Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex. Clinical Microbiology and Infection. 25(3). 379.e1–379.e7. 42 indexed citations
9.
Nguyen, Duc B., Isaac See, Alicia Shugart, et al.. (2015). Completeness of Methicillin-ResistantStaphylococcus aureusBloodstream Infection Reporting From Outpatient Hemodialysis Facilities to the National Healthcare Safety Network, 2013. Infection Control and Hospital Epidemiology. 37(2). 205–207. 9 indexed citations
10.
Soe, Minn, Jonathan R. Edwards, Dawn Sievert, et al.. (2015). Evaluating State-Specific Antibiotic Resistance Measures Derived from Central Line-Associated Bloodstream Infections, National Healthcare Safety Network, 2011. Infection Control and Hospital Epidemiology. 36(1). 54–64. 5 indexed citations
11.
Lindley, Megan C., et al.. (2014). Influenza vaccination performance measurement among acute care hospital-based health care personnel--United States, 2013-14 influenza season.. PubMed. 63(37). 812–5. 12 indexed citations
12.
Tosh, Pritish K., Sandra N. Bulens, Joelle Nadle, et al.. (2013). Characterization of Hospitalized Community-Onset Staphylococcus aureus Lower Respiratory Tract Infections Among Generally Healthy Persons 50 Years of Age or Younger. Infectious Diseases in Clinical Practice. 21(6). 359–365. 2 indexed citations
13.
Dudeck, Margaret A., Lindsey M. Weiner, Katherine Allen‐Bridson, et al.. (2013). National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module. American Journal of Infection Control. 41(12). 1148–1166. 461 indexed citations breakdown →
14.
Chitnis, Amit S., et al.. (2012). Device-Associated Infection Rates, Device Utilization, and Antimicrobial Resistance in Long-Term Acute Care Hospitals Reporting to the National Healthcare Safely Network, 2010. Infection Control and Hospital Epidemiology. 33(10). 993–1000. 37 indexed citations
15.
Zilberberg, Marya D., Ying P. Tabak, Dawn Sievert, et al.. (2011). Using Electronic Health Information to Risk-Stratify Rates of Clostridium difficile Infection in US Hospitals. Infection Control and Hospital Epidemiology. 32(7). 649–655. 34 indexed citations
16.
Duffy, Jonathan, Dawn Sievert, Marion Kainer, et al.. (2011). Effective State-Based Surveillance for Multidrug-Resistant Organisms Related to Health Ca re-Associated Infections. Public Health Reports. 126(2). 176–185. 7 indexed citations
17.
Sievert, Dawn, Mark L. Wilson, Melinda J. Wilkins, Brenda W. Gillespie, & Matthew L. Boulton. (2010). Public Health Surveillance for Methicillin-Resistant Staphylococcus aureus: Comparison of Methods for Classifying Health Care– and Community-Associated Infections. American Journal of Public Health. 100(9). 1777–1783. 7 indexed citations
18.
Sievert, Dawn, James T. Rudrik, Jean B. Patel, et al.. (2008). Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006. Clinical Infectious Diseases. 46(5). 668–674. 352 indexed citations
19.
Hidrón, Alicia, Jonathan R. Edwards, Jean B. Patel, et al.. (2008). Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infection Control and Hospital Epidemiology. 29(11). 996–1011. 3077 indexed citations breakdown →
20.
Sievert, Dawn, Jeffrey Hageman, Matthew L. Boulton, et al.. (2003). Infection with Vancomycin-ResistantStaphylococcus aureusContaining thevanAResistance Gene. New England Journal of Medicine. 348(14). 1342–1347. 852 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hilmar Wisplinghoff Breakdown of academic impact, for papers by Mary K. Hayden Breakdown of academic impact, for papers by Mario Venditti Breakdown of academic impact, for papers by Emilia Cercenado Breakdown of academic impact, for papers by Jan Kluytmans Breakdown of academic impact, for papers by Kyong Ran Peck Breakdown of academic impact, for papers by Alexander J. Kallen Breakdown of academic impact, for papers by Àlex Soriano Breakdown of academic impact, for papers by Susan M. Ray Breakdown of academic impact, for papers by Javier Garau
Rankless by CCL
2026